Yu-Jun Dai (Yujun Dai)

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 4

Top Topics

Respiratory Syndrome Coronavirus

Acute Myeloid Leukemia

Natural Killer Cells

Top Venues

Clinical and translational medicine

Molecular cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Da-Wei Wang, Xiaohu Shao, Qiang Wang, Xiaohong Pan, Yu-Jun Dai, Shuxian Yao, Tong Yin, Zhugang Wang, Jiang Zhu, Xiaodong Xi, Zhu Chen, Saijuan Chen, Guowei Zhang
Activated factor X targeted stored in platelets as an effective gene therapy strategy for both hemophilia A and B. Clinical and translational medicine 11 (3) (2022)
Ying Yang, Yu-Jun Dai, Xuejiao Yang, Songfang Wu, Yue-Ying Wang
DNMT3A Mutation-Induced CDK1 Overexpression Promotes Leukemogenesis by Modulating the Interaction between EZH2 and DNMT3A. Biomolecules 11 (6) (2021)
Yu-Jun Dai, Si-Yuan He, Fang Hu, Xue-Ping Li, Jian-Ming Zhang, Si-Liang Chen, Wei-Na Zhang, Hai-Min Sun, Da-Wei Wang
Bone marrow infiltrated natural killer cells predicted the anti-leukemia activity of MCL1 or BCL2 inhibitors in acute myeloid leukemia. Molecular cancer 20 (1) (2021)
Xue-Ping Li, Xin Huang, Yan-Mei Qin, Guo-Yan Wu, Cheng-Cai Liang, Yu-Jun Dai, Wei-Na Zhang
SARS-CoV-2-related IFITM3 in immune dysfunction and tumor microenvironment: An integrative analysis in pan-cancers. Clinical and translational medicine 11 (2) (2021)